Table 1

Comparison of baseline demographic variables and the incidence of a second ACL injury between GJH and non-GJH patients

VariableGJH
(n=50)
Non-GJH
(n=175)
P value
Age at reconstruction, mean±SD (years)22.3±6.425.0±8.10.031
Male, n (%)19 (38.0%)86 (49.1%)0.22
Height, mean±SD (cm)174.6±9.3175.1±9.50.79
Weight, mean±SD (kg)71.4±11.072.6±12.50.55
BMI, mean±SD (kg/m2)23.3±2.123.6±2.80.56
Right knee, n (%)30 (60.0%)96 (54.9%)0.63
Smoking n (%)1 (2.0%)1 (0.6%)0.79
Beighton score, median (range)6 (5-9)2 (1-4)
Time from injury to surgery, mean (95% CI) (months)4.90 (3.42 to 6.33)8.86 (5.28 to 12.44) n=1740.17
Graft type, n (%)0.25
 Hamstring tendon autograft34 (68.0%)139 (79.4%)
 Patellar tendon autograft16 (32.0%)32 (18.3%)
 Quadriceps tendon autograft01 (0.6%)
 Allograft02 (1.1%)
 Other01 (0.6%)
Time until RTS (Tegner activity level≥6), mean (95% CI) (months)9.2
(7.7 to 10.7)
11.5
(10.4 to 12.7)
0.031
Second ACL injury within 12 months of RTS, n (%)7 (14.0%)5 (2.9%)0.012
Ipsilateral second ACL injury
 None within 12 months of RTS46 (92.0%)171 (97.7%)
 0–4 months from RTS1 (2.0%)3 (1.7%)
 4–8 months from RTS2 (4.0%)0
 8–12 months from RTS1 (2.0%)1 (0.6%)
Contralateral second ACL injury
 None within 12 months of RTS47 (94.0%)174 (99.4%)
 0–4 months from RTS00
 4–8 months from RTS2 (4.0%)1 (0.6%)
 8–12 months from RTS1 (2.0%)0
Time from RTS to second ACL injury in patients with a 12-month or longer follow-up, mean (95% CI) (months)21.0
(11.3 to 30.6)
18.0
(9.3 to 26.6)
0.63
Cumulative incidence of a second ACL injury in patients with a 12-month or longer follow-up, n (%)15 (38.2%)14 (10.1%)<0.001
Ipsilateral second ACL injury8 (16.0%)7 (4.0%)
Contralateral second ACL injury7 (14.0%)7 (4.0%)
  • ACL, anterior cruciate ligament; BMI, body mass index; GJH, generalised joint hypermobility; N, number; RTS, return to sport.